• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基因治疗途径与新冠疫苗。

Gene therapy avenues and COVID-19 vaccines.

作者信息

Abu Abed Omar S

机构信息

Health Sciences Department, Arab American University in Palestine, Ramallah, Palestine.

出版信息

Genes Immun. 2021 Jun;22(2):120-124. doi: 10.1038/s41435-021-00136-6. Epub 2021 Jun 2.

DOI:10.1038/s41435-021-00136-6
PMID:34079091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8170448/
Abstract

2020 has witnessed unprecedented situations due to coronavirus pandemic that affected all aspects of life. The whole globe lived months of uncertainty before two companies have announced the incredible results of phase III clinical trials for two different mRNA-based vaccines.

摘要

2020年，由于新冠疫情，出现了前所未有的情况，影响了生活的方方面面。在两家公司宣布两种不同的基于信使核糖核酸的疫苗三期临床试验取得惊人成果之前，全球经历了数月的不确定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e2/8170448/83226c0962fd/41435_2021_136_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e2/8170448/83226c0962fd/41435_2021_136_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03e2/8170448/83226c0962fd/41435_2021_136_Fig1_HTML.jpg

相似文献

1
Gene therapy avenues and COVID-19 vaccines.基因治疗途径与新冠疫苗。
Genes Immun. 2021 Jun;22(2):120-124. doi: 10.1038/s41435-021-00136-6. Epub 2021 Jun 2.
2
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.美国基于mRNA的新冠疫苗接种后的心肌炎病例
JAMA. 2022 May 24;327(20):2019-2020. doi: 10.1001/jama.2022.5131.
3
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.美国基于mRNA的COVID-19疫苗接种后的心肌炎病例——回复
JAMA. 2022 May 24;327(20):2020-2021. doi: 10.1001/jama.2022.5134.
4
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BA.2.12.1、BA.4和BA.5亚变体的加强mRNA疫苗的持久性
N Engl J Med. 2022 Oct 6;387(14):1329-1331. doi: 10.1056/NEJMc2210546. Epub 2022 Sep 7.
5
Novel approaches for vaccine development.新型疫苗研发方法。
Cell. 2021 Mar 18;184(6):1589-1603. doi: 10.1016/j.cell.2021.02.030.
6
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.新冠病毒mRNA疫苗第四剂对奥密克戎毒株的效力
N Engl J Med. 2022 Apr 7;386(14):1377-1380. doi: 10.1056/NEJMc2202542. Epub 2022 Mar 16.
7
A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine.1例由新型冠状病毒肺炎信使核糖核酸疫苗引发的银屑病关节炎加重病例。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e427-e429. doi: 10.1111/jdv.18013. Epub 2022 Feb 23.
8
Incidence of Myocarditis after Messenger RNA Vaccine for COVID-19 in Young Male Recipients.年轻男性接种新冠病毒信使核糖核酸疫苗后心肌炎的发病率
Am J Cardiol. 2022 Jun 1;172:159-161. doi: 10.1016/j.amjcard.2022.02.010. Epub 2022 Mar 23.
9
COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.孕期接种新冠病毒mRNA加强针可增加母体和胎儿抗体。
JAMA. 2022 Jul 12;328(2):120-121. doi: 10.1001/jama.2022.11145.
10
Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre.接种AZD1222和BNT162b2新冠mRNA疫苗后银屑病发作：来自单一中心的12例报告
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e411-e415. doi: 10.1111/jdv.17965. Epub 2022 Feb 4.

引用本文的文献

1
Ionizable drug delivery systems for efficient and selective gene therapy.用于高效和选择性基因治疗的可离子化药物传递系统。
Mil Med Res. 2023 Feb 27;10(1):9. doi: 10.1186/s40779-023-00445-z.
2
Gene Therapeutic Delivery to the Salivary Glands.基因治疗递送至唾液腺。
Adv Exp Med Biol. 2023;1436:55-68. doi: 10.1007/5584_2023_766.
3
A call for immediate action to increase COVID-19 vaccination uptake to prepare for the third pandemic winter.呼吁立即采取行动，提高 COVID-19 疫苗接种率，为第三次大流行冬季做准备。

本文引用的文献

1
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.FDA 授权的 mRNA COVID-19 疫苗根据多州医疗系统综合的真实世界证据有效。
Med. 2021 Aug 13;2(8):979-992.e8. doi: 10.1016/j.medj.2021.06.007. Epub 2021 Jun 29.
2
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.mRNA-1273疫苗引发的血清中和活性。
N Engl J Med. 2021 Apr 15;384(15):1468-1470. doi: 10.1056/NEJMc2102179. Epub 2021 Mar 17.
3
Neutralizing Activity of BNT162b2-Elicited Serum.BNT162b2诱导血清的中和活性
Nat Commun. 2022 Dec 6;13(1):7511. doi: 10.1038/s41467-022-34995-y.
4
Impact of Degree of Ionization and PEGylation on the Stability of Nanoparticles of Chitosan Derivatives at Physiological Conditions.在生理条件下，离解度和聚乙二醇化程度对壳聚糖衍生物纳米粒子稳定性的影响。
Mar Drugs. 2022 Jul 25;20(8):476. doi: 10.3390/md20080476.
5
Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity.关于包括COVID-19大流行在内的各种病毒感染、靶向抗病毒药物和疫苗的重要观点。
Mol Biomed. 2022 Jul 15;3(1):21. doi: 10.1186/s43556-022-00078-z.
6
The impact of COVID-19 on sustainable development.新冠疫情对可持续发展的影响。
Croat Med J. 2022 Jun 22;63(3):213-220. doi: 10.3325/cmj.2022.63.213.
7
Transdermal delivery for gene therapy.经皮给药基因治疗。
Drug Deliv Transl Res. 2022 Nov;12(11):2613-2633. doi: 10.1007/s13346-022-01138-1. Epub 2022 May 10.
8
Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.脂质纳米粒子的修饰：基于核酸的免疫治疗的有效递药系统。
Molecules. 2022 Mar 17;27(6):1943. doi: 10.3390/molecules27061943.
9
Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections.基因疫苗作为一种灵活的工具，用于克服侵袭性真菌感染的免疫复杂性。
Front Microbiol. 2021 Dec 15;12:789774. doi: 10.3389/fmicb.2021.789774. eCollection 2021.
10
Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules.靶向新冠病毒感染中的炎性小体激活：基于RNA干扰的治疗性分子递送
Biomedicines. 2021 Dec 3;9(12):1823. doi: 10.3390/biomedicines9121823.
N Engl J Med. 2021 Apr 15;384(15):1466-1468. doi: 10.1056/NEJMc2102017. Epub 2021 Mar 8.
4
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
5
PEGylated polymeric nanocapsules for oral delivery of trypsin targeted to the small intestines.用于将胰蛋白酶靶向递送至小肠的聚乙二醇化聚合物纳米胶囊的口服递送。
Int J Pharm. 2021 Jan 5;592:120094. doi: 10.1016/j.ijpharm.2020.120094. Epub 2020 Nov 14.
6
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
7
Design of experiment (DoE)-driven and uptake studies of exosomes for pancreatic cancer delivery enabled by copper-free click chemistry-based labelling.基于无铜点击化学标记的胰腺癌递送外泌体的实验设计（DoE）驱动及摄取研究。
J Extracell Vesicles. 2020 Jun 19;9(1):1779458. doi: 10.1080/20013078.2020.1779458.
8
Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems.新型阳离子基因脂质体与环糊精的评价 通过薄膜水化和微流控系统制备。
Sci Rep. 2019 Oct 22;9(1):15120. doi: 10.1038/s41598-019-51065-4.
9
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives.用于鼻-脑递送的脂质体制剂：最新进展与未来展望
Pharmaceutics. 2019 Oct 17;11(10):540. doi: 10.3390/pharmaceutics11100540.
10
Lysozyme and DNase I loaded poly (D, L lactide-co-caprolactone) nanocapsules as an oral delivery system.载溶菌酶和脱氧核糖核酸酶 I 的聚（D，L 丙交酯-己内酯）纳米胶囊作为口服递药系统。
Sci Rep. 2018 Sep 3;8(1):13158. doi: 10.1038/s41598-018-31303-x.